100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
2484719-14-2Abiraterone Ethyl Ether Impurity
● Under Development
| Catalogue No.: | VL830020 |
|---|---|
| CAS No.: | 2484719-14-2 |
| Mol. Formula: | C26H35NO |
| Mol. Weight: | 377.57 g/mol |
Additional information on CAS 2484719-14-2
Parent drug
AbirateroneIUPAC Name
3-((3S,8R,9S,10R,13S,14S)-3-ethoxy-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridinePharmacopoeial Synonyms
N/AOther Synonyms
N/ASmiles
C[C@@]12C(C3=CC=CN=C3)=CC[C@@]1([H])[C@]4([H])CC=C5C[C@@H](OCC)CC[C@]5(C)[C@@]4([H])CC2InChI
InChI=1S/C26H35NO/c1-4-28-20-11-13-25(2)19(16-20)7-8-21-23-10-9-22(18-6-5-15-27-17-18)26(23,3)14-12-24(21)25/h5-7,9,15,17,20-21,23-24H,4,8,10-14,16H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1Description
Abiraterone Ethyl Ether Impurity or 1-((8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl)ethan-1-one,is a derivative of steroidal progesterone and is used in the treatment of prostate cancer.References
Thakur, Abhimanyu, et al. “Abiraterone Acetate in the Treatment of Prostate Cancer.†Biomedicine & Pharmacotherapy, vol. 101, May 2018, pp. 211–218, 10.1016/j.biopha.2018.02.067.Request a Quote
« * » indique les champs nécessaires
Other products related to Abiraterone impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
